Trials / Completed
CompletedNCT00283946
A Double-blind, Group-comparison Study Using Zolpidem (Myslee) as a Comparative Drug in Patients With Insomnia
FK199B (Zolpidem MR Tablet) Phase III Clinical Study -A Double-blind, Group-comparison Study Using Zolpidem (Myslee) as a Comparative Drug in Patients With Insomnia -
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 876 (actual)
- Sponsor
- Astellas Pharma Inc · Industry
- Sex
- All
- Age
- 20 Years – 64 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to investigate the efficacy and safety of FK199B (Zolpidem MR Tablet) in patients with insomnia by a randomized, double-blind, group-comparison study using zolpidem (Myslee) as a comparative drug
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Zolpidem MR | Oral |
| DRUG | Zolpidem | Oral |
Timeline
- Start date
- 2006-02-01
- Primary completion
- 2007-11-01
- Completion
- 2007-11-01
- First posted
- 2006-01-31
- Last updated
- 2014-08-20
Locations
8 sites across 1 country: Japan
Source: ClinicalTrials.gov record NCT00283946. Inclusion in this directory is not an endorsement.